LSP and EQT merge to create top-10 investment firm
Life Sciences investor LSP is set to being acquired by Europe’s largest equity specialist EQT AB.
Novartis inks US-$1.3bn deal with Dunad Therapeutics
Dunad Therapeutics Ltd had entered into a $1.3bn option deal with Swiss pharma major Novartis AG to develop targeted protein degrader therapies.
Agomab Therapeutics to acquire Origo Biopharma
Belgian Agomab Therapeutics NV is expanding its European footprint by acuiring Barcelona-based fibrosis therapy specialist Origo Biopharma.
Sofinnova Capital X Fund closed at 472m
Paris-based life sciences venture capital firm Sofinnova Partners has closed the largest early-stage healthcare VC fund in Europe.
Curevac withdraws MAA of CVnCoV
German CureVac N.V. has withdrawn its application for market approval of its COVID-19 vaccine candidate and will focus on the development of a second-generation vaccine.
Delivering on Europe´s Green Deal EFIB 2021 in Vienna
Leading industry leaders, SMEs representatives and academia are joining in Vienna, Austria, at the 14th European Forum for Industrial Biotechnology and the Bioeconomy (EFIB), from 6th to 7th of October, organised by EuropaBio and conference partners.
COVID-19 immunisation set to get FDA EUA
Pharma giant AstraZeneca has submitted data to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its antibody duo AZD7442.
BioNTech investigates cancer vaccine BNT122 in Phase II trial
BionTech SE, which has been very successful in the field of corona vaccines, is starting phase II tests with its colorectal cancer candidate BNT122.
Advent France Biotechnology launches 86m fund
Advent France Biotechnologys has launched a second biotech seed fund with a first close at 86m. Since 2017, the French state fund has financed 15 startups in France, Spain, Belgium and Ireland with 68m.
Team identifies factors for COVID-19 vaccine protection
A comparison of immune correlates of AstraZeneca’s Phase II/III COVID-19 vaccine trial shows what antibodiy titer is required to prevent symptomatic disease.